Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program.

Schizophrenia (Heidelberg, Germany)·2025
Same author

The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.

Schizophrenia (Heidelberg, Germany)·2025
Same author

Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample.

Schizophrenia (Heidelberg, Germany)·2025
Same author

Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2025
Same author

Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors.

Psychological medicine·2025
Same author

Prioritizing Brain Health in Youth: Bringing Neuroscience to Society and Informing Policy, Lessons Learnt from the European Brain Council Expert Meeting Held at the Federation of European Neuroscience Societies Forum 2024.

The European journal of neuroscience·2025

Related Experiment Video

Updated: Jul 5, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
05:19

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Guy M Goodwin1, Ian Anderson, Celso Arango

  • 1University Department of Psychiatry, Warneford Hospital, Oxford OX3 7JX, UK. guy.goodwin@psych.ox.ac.uk

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|May 27, 2008
PubMed
Summary

Distinguishing unipolar (UP) from bipolar (BP) depression is challenging, with a significant risk of initial UP diagnoses converting to BP over time. Research is needed for reliable diagnostic criteria and effective treatments for bipolar depression, especially in children and adolescents.

Related Experiment Videos

Last Updated: Jul 5, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
05:19

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Area of Science:

  • Psychiatry and Mental Health
  • Clinical Psychology
  • Neuroscience

Background:

  • The Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) is the current standard for diagnosing mental health conditions.
  • Prevalence estimates for bipolar disorder (BP) are consistent across European and US general population samples.
  • First onset of bipolar mood disorder typically occurs in mid-teenage years and twenties, often manifesting as a major depressive episode or hypomania.

Purpose of the Study:

  • To highlight the diagnostic challenges in differentiating unipolar (UP) and bipolar (BP) depression.
  • To underscore the need for improved diagnostic criteria and treatment strategies for bipolar depression, particularly in pediatric populations.
  • To discuss the methodologies and considerations for clinical trials in bipolar depression.

Main Methods:

  • Review of existing diagnostic criteria (DSM-IV-TR) and epidemiological data for bipolar disorder.
  • Analysis of challenges in cross-sectional differentiation between unipolar and bipolar depression.
  • Discussion of methodologies for clinical trials, including placebo-controlled designs, outcome measures (e.g., HAM-D, MADRS), and patient selection criteria (e.g., rapid cycling, co-morbid anxiety).

Main Results:

  • Reliable cross-sectional criteria to distinguish UP from BP depression are lacking, with a longitudinal risk of over 10% for UP diagnoses converting to BP.
  • Bipolar I disorder is rare in prepubertal children using unmodified DSM-IV-TR criteria; broad diagnoses risk confounding.
  • Anxiety is common in bipolar populations, and rapid cycling patients can be included in trials if severity criteria are met.

Conclusions:

  • A probabilistic approach to UP/BP distinction is recommended for future diagnostic revisions (e.g., DSM-V).
  • Empirical studies and longitudinal assessments are crucial for validating broadly defined pediatric bipolar disorder phenotypes.
  • Standardized methodologies, including monotherapy trials against placebo and appropriate rating scales, are essential for effective bipolar depression treatment research.